Back to results

TEST DEBUG

TEST
Keywords: TEST DEBUG
Patent Application number: European Procedure (Patents) (EPA) - 07 Déc. 2018 - 18306643.0
Inventors:
GODOT Véronique,TCHERAKIAN Colas,LEVY Yves,ANNANE Djillali

Reference:

BIO18523-D2

Business Developper
contact
Inserm Transfert
Business Developer
Patent filling date: null
Rare disease: No
Second indication: No

You might also be interested in

4921241AG6

Test rt 1707 v2

Test RT 1707 v2 […]

Read more
RT00626

Ug5ln gal4-hmr cell line

UG5LN were generated by transfection of osteocarcinoma cancer U2OS cells with the […]

Read more
RT00625

Ug5ln cell line

UG5LN were generated by transfection of osteocarcinoma cancer U20S cells with the […]

Read more
RT00624

Ualh cell line

UALH were generated by transfection of osteocarcinoma cancer U2OS cells with the […]

Read more
RT00586

Ualh har cell line

UALH were generated by transfection of osteocarcinoma cancer U2OS cells with the […]

Read more
RT00582

Palm cell line

PALM were generated by co-transfection of cervical cancer PC3 cells with the […]

Read more
RT00583

Meln (her alpha) cell line

MELN were generated by transfection of breasr cancer MCF-7 cells with the […]

Read more
RT00623

Hrln (hrar alpha) cell line

HRLN were generated by transfection of cervical cancer HeLa cells with the […]

Read more
RT00622

Hmln (hgr) reporter cell line

HMLN were generated by transfection of cervical cancer HeLa cells with the MMTV- […]

Read more
RT00558

Hg5ln gal4-hppar alpha cell line

HG5LN were generated by transfection of cervical cancer HeLa cells with the […]

Read more
RT00559

Hg5ln gal4-hppar gamma cell line

HG5LN were generated by transfection of cervical cancer HeLa cells with the […]

Read more
RT00569

Hg5ln gal4-hppar beta/delta cell line

HG5LN were generated by transfection of cervical cancer HeLa cells with the […]

Read more